HALO - Company ID 0001159036
As of 2026-09-07, HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $13.07 B, making it the #812 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $13.07 B |
| 2026-09-06 | $13.07 B |
| 2026-09-05 | $13.07 B |
| 2026-09-04 | $13.09 B |
| 2026-09-03 | $13.14 B |
| 2026-09-02 | $12.93 B |
| 2026-09-01 | $12.78 B |
| 2026-08-31 | $12.58 B |
| 2026-08-30 | $12.50 B |
| 2026-08-29 | $12.50 B |
| 2026-08-28 | $12.49 B |
| 2026-08-27 | $12.68 B |
As of 2026-09-07, HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $13.07 B, making it the #812 most valuable US-listed company.
HALOZYME THERAPEUTICS, INC. is the #812 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $12.70 B |
| 2026-08-25 | $12.93 B |
| 2026-08-24 | $12.89 B |
| 2026-08-23 | $12.83 B |
| 2026-08-22 | $12.83 B |
| 2026-08-21 | $12.83 B |
| 2026-08-20 | $12.59 B |
| 2026-08-19 | $12.77 B |
| 2026-08-18 | $12.44 B |
| 2026-08-17 | $12.22 B |
| 2026-08-16 | $11.70 B |
| 2026-08-15 | $11.70 B |
| 2026-08-14 | $11.68 B |
| 2026-08-13 | $11.94 B |
| 2026-08-12 | $12.07 B |
| 2026-08-11 | $12.17 B |
| 2026-08-10 | $12.19 B |
| 2026-08-09 | $12.23 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.